Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

13.30
Delayed Data
As of 3:00pm ET
 +0.25 / +1.92%
Today’s Change
6.17
Today|||52-Week Range
14.69
+7.34%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close13.05
Today’s open13.10
Day’s range12.15 - 13.43
Volume59,944
Average volume (3 months)157,737
Market cap$454.1M
Dividend yield--
Data as of 3:00pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-22.82%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp+0.45+4.26%
CYTKCytokinetics Inc-0.03-0.22%
OTICOtonomy Inc+1.35+8.91%
NERVMinerva Neuroscience...+0.35+2.64%
Data as of 3:15pm ET, 12/06/2016

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs